You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematological malignancy

Showing 1 - 25 of 2,432
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Complications in Hematological Malignancies

Not yet recruiting
  • Hematologic Malignancy
    • Assiut, Egypt
      Assiut university
    Mar 6, 2023

    Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)

    Not yet recruiting
    • Hematological Malignancy
    • Neutropenia
    • Morgantown, West Virginia
      Aaron Cumpston
    Sep 12, 2022

    Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

    Recruiting
    • Neoplasm, Plasma Cell
    • Lymphoma
    • Comprehensive Geriatric Assessment
    • Toulouse, France
      University Hospital Toulouse
    Oct 12, 2022

    Participants Previously Treated With Century Therapeutics

    Not yet recruiting
    • Hematological Malignancy
    • Solid Tumor Malignancy
    • No Intervention
    • (no location specified)
    Mar 3, 2023

    Hematologic Malignancy Trial in Copenhagen (HM-PRO)

    Active, not recruiting
    • Hematologic Malignancy
    • HM-PRO
    • Copenhagen, Denmark
      Dept. of Hematology
    Jun 14, 2022

    Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

    Not yet recruiting
    • Hematological Malignancy
    • Solid Tumor
    • (no location specified)
    Apr 24, 2023

    CD7+ Acute Leukemia, CD7+ Lymphoma Trial in Hangzhou (anti-CD7 CAR-T)

    Recruiting
    • CD7+ Acute Leukemia
    • CD7+ Lymphoma
    • anti-CD7 CAR-T
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital，College of Medicine, Zhejiang Univ
    Sep 18, 2022

    Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)

    Recruiting
    • Haematological Malignancy
    • 6 sessions of adapted physical activity after stem cell transplant
    • Nice, France
      CHU NICE, hopital ARCHET 1, hématologie
    Jun 13, 2022

    Membrane Target Detection for Leukemia Treatment

    Recruiting
    • Hematological Malignancy
    • Study sample collection
    • Columbia, Missouri
      University of Missouri
    Dec 29, 2021

    Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)

    Not yet recruiting
    • Solid Tumor
    • Hematological Malignancy
    • Locus Health iPhone App
    • Fairfax, Virginia
      Inova Schar Cancer Institute
    Oct 24, 2023

    Bone Marrow Disease, Hematological Malignancy Trial in Kayseri (Musictherapy)

    Active, not recruiting
    • Bone Marrow Disease
    • Hematological Malignancy
    • Musictherapy
    • Kayseri, Turkey
      Kayseri City Hospital
    Jun 8, 2023

    Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

    Recruiting
    • Hematological Malignancy
    • Cancer-Related Anemia
    • Shengxuening Tablet
    • Ferrous succinate
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Mar 13, 2023

    Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)

    Recruiting
    • Hematological Malignancy
    • COVID-19
    • Anti-COVID-19 Antibody SA55 for Injection
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Jan 9, 2023

    The Optimization of Haploidentical Hematopoietic Stem Cell

    Not yet recruiting
    • Hematological Malignancy
    • ATG
    • Post-transplantation cyclophosphamide
    • Beijing, Beijing, China
      People's Hospital of Peking University
    Nov 28, 2022

    Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

    Recruiting
    • Hematological Malignancy
    • Ningbo, Zhejiang, China
      The Affiliated People's Hospital of Ningbo University.
    Aug 18, 2022

    Hematological Malignancy Trial (Thymoglobulin Injectable Product)

    Not yet recruiting
    • Hematological Malignancy
    • Thymoglobulin Injectable Product
    • (no location specified)
    Sep 27, 2023

    Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)

    Not yet recruiting
    • Hematological Malignancy
    • Fludarabine Phosphate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

    Recruiting
    • Solid Tumor
    • Hematological Malignancy
    • East Melbourne, Victoria, Australia
    • +4 more
    Jan 11, 2023

    Hematological Malignancy Trial in Roskilde (Taste-test, Standard care)

    Enrolling by invitation
    • Hematological Malignancy
    • Taste-test
    • Standard care
    • Roskilde, Denmark
      Department of Hematology
    May 5, 2022

    Hematological Malignancy, Lymphoma Trial in Canton (SG2501)

    Recruiting
    • Hematological Malignancy
    • Lymphoma
    • Canton, Ohio
      Gabrail Cancer Center Research, LLC
    Aug 3, 2022

    CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

    Not yet recruiting
    • CXCR4
    • +2 more
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Feb 15, 2022

    Hematologic Malignancy Trial in Tianjin (BR108 injection)

    Recruiting
    • Hematologic Malignancy
    • BR108 injection
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 25, 2023

    GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)

    Active, not recruiting
    • GVHD, Chronic
    • Hematological Malignancy
    • Lee Symptom Scala
    • Copenhagen, Denmark
      Rigshospitalet
    Jul 14, 2022

    Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)

    Recruiting
    • Hematological Malignancy
    • Multiple Myeloma
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Oct 4, 2022

    Following Treatment With Fate Therapeutics' Engineered Cellular

    Terminated
    • Hematological Malignancy
    • Genetically engineered NK cells
    • Phoenix, Arizona
    • +4 more
    Aug 24, 2022